Tianjin TEDA Biomedical Engineering Co (FRA:TJJ) GF Value Rank: 0 (As of Aug. 28, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:TJJ Tianjin TEDA Biomedical Engineering Co Ltd FRA:TJJ
28 GF Score
Price €0.02
GF Value €0.01
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is Tianjin TEDA Biomedical Engineering Co GF Value Rank?

Tianjin TEDA Biomedical Engineering Co has the GF Value Rank of 0.

GF Value Rank evaluates the exclusive GuruFocus valuation and performance of a stock, rated on a scale from 1 to 10. It is determined by the price-to-GF-Value (P/GF Value) ratio, a proprietary metric calculated based on historical multiples along with an adjustment factor based on a company's past returns and growth and future estimates of the business' performance.

GuruFocus found that for valuation, we cannot simply give stocks a better GF Value rank simply because they have a lower P/GF Value ratio. Backtesting shows that over the long term, the two worst-performing groups are the most expensive group (with the highest P/GF Value ratio) and the least expensive group (with the lowest P/GF Value ratio).

We can understand why the most expensive group underperforms. We were initially puzzled by the underperformance of the least expensive group, but we realized there is a reason why some stocks are super cheap. If they look too undervalued, it is often because the businesses behind them are poor quality. The market realized this and gave them low valuations. In a way, the market is efficient.

After multiple backtesting analyses, we granted the stocks in third-cheapest percentile the highest GF Value rank, as they have performed the best over a full market cycle. Stock performance is actually not as sensitive to valuation as it is to growth and profitability. On average, the companies in the 20%-50% valuation groups have similar performances. Therefore, we should avoid the most expensive and the least expensive stocks. We can be more tolerant of valuation.

A higher score indicates a stock with a relatively low valuation and substantial potential for outperformance. Conversely, a lower score often reflects stocks that are either highly overvalued or deeply undervalued, both of which tend to underperform.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.


Tianjin TEDA Biomedical Engineering Co GF Value Rank Related Terms

FRA:TJJ
28GF Score
Tianjin TEDA Biomedical Engineering Co Ltd FRA:TJJ
GF Value Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Tianjin TEDA Biomedical Engineering Co (FRA:TJJ) Overvalued in 2026?

Based on GuruFocus' analysis, Tianjin TEDA Biomedical Engineering Co stock appears to be overvalued. The current stock price of €0.02 is trading 115% above its estimated GF Value™ of €0.01. GuruFocus considers Tianjin TEDA Biomedical Engineering Co to be Significantly Overvalued.

Key valuation signals for FRA:TJJ:

  • GF Value Rank: 0
  • GF Value™: €0.01 vs. price of €0.02 (115% above fair value)
  • GF Score™: 28/100 with 8 warning signs

No single metric tells the full story. See the FRA:TJJ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Tianjin TEDA Biomedical Engineering Co Business Description

Other Exchanges 08189:Hong Kong
Address No. 80, The 4th Avenue, 9th Floor, Block A2, Tianda Hi-Tech Park, TEDA Tianjin, Tianjin, CHN
Tianjin TEDA Biomedical Engineering Co Ltd principally engages in manufacture and sale of biological compound fertiliser products and elderly care and health care services and related products. The group is principally engaged in manufacturing and selling biological compound fertilisers, AI health & elderly care products and services. It operates in two segments namely; fertilisers products; and AI health & elderly care products and services. The company generates a majority of its revenue from the Fertilisers products segment. The People's Republic of China is the primary geographical market for the company.
28GF Score

Get the complete analysis for FRA:TJJ

GF Value Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.02
Price
€0.01
GF Value